ABT vs BETA · P/E 25, rev $44.33B vs rev $8.9M
Abbott Laboratories (ABT) versus Beta Technologies, Inc. (BETA) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Beta Technologies, Inc. (BETA) is a aerospace & defense company listed on NYSE.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported BETA revenue for 2025-09-30 was $8.9M. Net income was -$437.2M. Revenue was up 190.9% from 2024-09-30 to 2025-09-30. BETA currently screens at market cap $3.72B.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. BETA currently screens at market cap $3.72B.
Not investment advice. Open the ABT and BETA stock pages for the full models.
Not investment advice.